0001567619-22-012468.txt : 20220607
0001567619-22-012468.hdr.sgml : 20220607
20220607173454
ACCESSION NUMBER: 0001567619-22-012468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING THOMAS BRAXTON
CENTRAL INDEX KEY: 0001279309
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39041
FILM NUMBER: 221002083
MAIL ADDRESS:
STREET 1: 91 JAMES AVENUE
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001692830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813039831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
BUSINESS PHONE: 415-505-0809
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
4
1
doc1.xml
FORM 4
X0306
4
2022-06-03
0
0001692830
Satsuma Pharmaceuticals, Inc.
STSA
0001279309
KING THOMAS BRAXTON
C/O SATSUMA PHARMACEUTICALS, INC.
400 OYSTER POINT BOULEVARD, SUITE 221
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
3.46
2022-06-03
4
A
0
30000
0.00
A
2032-06-02
Common Stock
30000
30000
D
The option shall vest in full and become exercisable on the day immediately preceding the 2023 Annual Meeting.
/s/ Thomas P. O'Neil as Attorney in Fact for Thomas B. King
2022-06-07